Foot and Mouth Disease Vaccines Market Shares, Strategies and Opportunities 2030
Foot and Mouth Disease Vaccines Market: Introduction
Transparency Market Research has published a new report titled ‘Global Foot and Mouth Disease Vaccines Market’. According to the report, the global foot and mouth disease vaccines market was valued at US$ 5.5 Bn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030. Foot and mouth disease (FMD) is an acute viral and highly contagious disease, affecting various economically important livestock species. The FMD virus affects pigs, cows, goats, sheep, and deer.
Animals with FMD develop fever and blisters on the lips and tongue in the mouth, on the mammary glands, and around the hooves. The foot and mouth disease is a highly contagious disease of cloven-hoofed animals. In countries where food and farm animals are essential for subsistence agriculture, outbreaks of FMD seriously affect food security and development. Substantial progress in FMD virus research at the molecular, cellular, and live animal levels has been made in the last few decades.
Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2480
In terms of type, the global foot and mouth disease vaccines market has been bifurcated into conventional vaccines and emergency vaccines. The conventional vaccines segment has been divided into aluminum hydroxide/saponin-based vaccines and oil-based vaccines. The conventional vaccines segment accounted for major share of the global foot and mouth disease vaccines market in 2019. The segment is anticipated to expand at a high CAGR during the forecast period, owing to the rise in the need & demand for prevention of the disease across the world.
Based on application, the global foot and mouth disease vaccines market has been classified into cattle, sheep & goat, pigs and others (antelope, deer, bison, and camelids). The cattle segment held a significant share of the global foot and mouth disease vaccines market in 2019.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2480
Foot and Mouth Disease Vaccines Market: Prominent Regions
North America held major share of the global foot and mouth disease vaccines market in 2019. Highly structured animal healthcare industry, presence of key players, and growth strategies adopted by these players are the major factors driving the foot and mouth disease vaccines market in the region. Rise in awareness about the benefits of prevention of diseases and increase in animal healthcare expenditure augments the foot and mouth disease vaccines market in North America.
Asia Pacific held the second largest share of the global foot and mouth disease vaccines market in 2019. The growth of the foot and mouth disease vaccines market in Asia Pacific can be attributed to rise in acute viral diseases and well-developed animal healthcare sector. The foot and mouth disease vaccines market in Asia Pacific is likely to grow at a rapid pace during the forecast period.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2480
The development of vaccines and other pharma products to cope with zoonotic disease concerns and a rise in awareness leading to routine checkup and diagnosis are the major factors anticipated to fuel the growth of the foot and mouth disease vaccines market in the region.
Foot and Mouth Disease Vaccines Market: Key Players
Key players are expanding their footprint to consolidate their positions in the global foot and mouth disease vaccines market. Greater emphasis on prevention and wellness by veterinarians and owners presents lucrative opportunities to key players to increase their share in the global foot and mouth disease vaccines market. Hence, manufacturers are engaging in new product development, collaborations, and distribution to gain market share.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2480
Leading players operating in the global foot and mouth disease vaccines market include India Immunological Ltd., Merck Animal Health, Brilliant Bio Pharma Ltd., Ceva Santé Animale, Boehringer Ingelheim GmbH, Biovet Private Limited, Biovencer Healthcare Private Limited, Vetal Animal Health Products S.A., and Biogenesis Bago SA.
More Trending Reports by Transparency Market Research –
Dermal Filler Market: https://www.transparencymarketresearch.com/us-dermal-filler-market.html
Particle Therapy Market: https://www.transparencymarketresearch.com/particle-therapy-market.html
Physician Dispensed Cosmeceuticals Market: https://www.transparencymarketresearch.com/physician-dispensed-cosmeceuticals-market.html
Hernia Repair Devices Market: https://www.transparencymarketresearch.com/hernia-repair-devices.html
Preventive Healthcare Technologies & Services Market: https://www.transparencymarketresearch.com/preventive-healthcare-technologies.html
Coronary Stents Market: https://www.transparencymarketresearch.com/coronary-stents-market.html
Hyperbaric Oxygen Therapy Devices Market: https://www.transparencymarketresearch.com/hbo-therapy-devices.html
Glioblastoma Multiforme Treatment (GBM) Market: https://www.transparencymarketresearch.com/pipeline-review-of-glioblastoma-treatment-market.html
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
www.biospace.com/article/mood-disorder-treatment-market-increasing-prevalence-of-mood-disorder-is-anticipated-to-drive-the-market
Sterile Vials Market Projected to Witness Vigorous Expansion by 2031
Sterile Vials Market: Introduction
According to the report, the global sterile vials market was valued over US$ 4.6 Bn in 2020 and is projected to expand at a CAGR of ~8% from 2021 to 2031. Growth of biologics and combination drug/device products across the globe, increase in global geriatric population, and rise in awareness among consumers about infections are anticipated to propel the global sterile vials market from 2021 to 2031.
North America is projected to be a highly attractive market for sterile vials during the forecast period. The region is anticipated to account for the largest share of the global market by 2031. Easy availability of raw materials for medical packaging in the region is expected to drive the market in North America. Increase in capital investment by leading manufacturers in the pharmaceutical packaging industry augments the sterile vials market in the region. For instance, in September 2017, Schott AG expanded manufacturing in the U.S. with investment in new generation of pharmaceutical sterile vials. International technology group Schott increased investment in the latest generation of pharmaceutical vials, mapping a future of stronger packaging options for pharmaceutical companies.
Request a PDF Sample –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77624
Europe is likely to be the second most attractive market for sterile vials during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2021 to 2031. Increase in development of biologics, antibody-drug conjugates, and monoclonal antibodies have driven the demand for sterile vials in the region. This fuels the growth of the sterile vials market in Europe during the forecast period.
High Adoption of Glass Vials Compared to Alternative Containers to Drive Market
Drug and pharmaceutical manufacturers need to maintain the required quality of sensitive medicines, while storing and supplying. Drugs and medicines come in contact with drug storage containers made of aluminum and other vessels that impart some amount of flavor into the drugs, which degrades the quality of the drugs. However, glass vials are non-reactive with the drug stored in them. Moreover, these glass vials are dust-resistant and easy to clean. Furthermore, features such as longer shelf life and contamination-free storage increase the popularity of glass vials.
Request for Analysis of COVID19 Impact on Sterile Vials Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77624
Rise in inclination of various end users, such as biopharmaceutical companies, CMOs, and clinical labs toward glass vials drives the global sterile vials market. Moreover, glass vials are easily recyclable and glass is considered eco-friendly material, which propels its popularity. This shift in focus of end users from conventional containers and vials to glass vials augments the global sterile vials market.
Capital Investment by Leading Manufacturers in Sterile Vials Propels Global Market
Rapid expansion of the global healthcare industry fuels the expansion of the global sterile vials market. Increase in demand for pharmaceutical products across the world is estimated to create significant opportunities for pharmaceutical packaging manufacturers during the forecast period. Leading manufacturers invest in sterile vials to consolidate their market position.
In June 2020, Corning, Inc. received US$ 204 Mn in funding to expand domestic manufacturing capacity of Corning Valor Glass vials to support the vaccination and treatment of billions of patients under White House’s Operation Warp Speed Initiative.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77624
Consistent capital investment by prominent sterile vials manufacturers to expand global footprint creates significant opportunities in the global market. Furthermore, various initiatives by governments to improve healthcare facilities in underdeveloped regions augment the market.
Sterile Empty Vial to Dominate Market
In terms of product, the global sterile vials market has been classified into sterile empty vial, sterile liquid filled vial, and individual sterilized components (ISCs). The sterile empty vial segment held major market share in 2020 and the trend is projected to continue during the forecast period. The segment is anticipated to register the highest market attractiveness during the forecast period.
2ml to 5ml Vials to be Highly Attractive
Based on volume, the global sterile vials market has been categorized into <2ml, 2ml to 5ml, 5ml to 10ml, 10ml to 20ml, and >20ml. The 2ml to 5ml segment accounted for a major share of 28.84% of the global sterile vials market in 2020. The 2ml to 5ml segment is anticipated to create incremental opportunity of US$ 2,276.6 Mn during the forecast period. The segment is expected to capture 30.12% market share by 2031. The segment is likely to expand at the highest CAGR of 8.8% from 2021 to 2031. Rapid expansion of the pharmaceutical industry is projected to create significant opportunities for manufacturers of 5 ml to 10 ml sterile vials.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=77624
Glass to be Preferred Materials
In terms of material, the global sterile vials market has been bifurcated into glass and plastic. The glass segment held 79.79% share of the global sterile vials market in 2020. The segment is expected to gain 114 basis points to reach 80.93% by 2031. The segment is likely to reach US$ 9,745.2 Mn by 2031, expanding at a CAGR of 8.5% during the forecast period. Glass vials are specifically designed to withstand extreme conditions encountered during the lyophilization process, with a flat bottom to optimize heat transfer. A 30% reduction in vial weight, uniform wall thickness for better mechanical resistance, and standard 20mm ISO neck compatible with all closures and reconstitution systems on the market augment the segment.
Competition Landscape in Sterile Vials Market
The report provides profiles of leading players operating in the global sterile vials market. These include Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma S.p.a., Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH, Gerresheimer AG, Nipro Corporation, O.Berk Company, Pacific Vial, Piramal Glass (Piramal Enterprises Ltd.), Schott AG, SDG Pharma, Shandong Pharmaceutical Glass Co. Ltd., SiO2 Materials Science, Stevanato Group, Thermo Fisher Scientific, Inc., and West Pharmaceutical Services, Inc.
More Trending Reports by Transparency Market Research –
Gene Therapy Market:
Adhesion Barriers Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Equine Supplement Products Market to be at Forefront by 2027
Transparency Market Research (TMR) has published a new report titled, “Equine Supplement Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global equine supplement products market was valued at US$ 75.2 Mn in 2018 and is projected to expand at a CAGR of 3.5 % from 2019 to 2027. Increase in incidence of equine diseases, rise in demand for protein/amino acid supplements, and surge in awareness about preventive care among equine owners are anticipated to augment the global equine supplement products market from 2019 to 2027.
Request a PDF Sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66551
Growth of Equine Health Industry
Incidence of equine diseases is increasing, with joint infections, bacterial infections, and upper respiratory infections being the most common health concerns. Therefore, demand for equine health products including supplements containing vitamins, minerals, amino acids, and other micro-nutrients is increasing. In case of racing horses, the horse owners and caretakers focus on improving joint & digestive health and performance recovery. They also take consultation from veterinary health care providers to better understand the use of horse feeds & supplements to promote growth and overall health of horses.
Furthermore, rise in trend of gambling, horse racing, and sports provides opportunities for market players in the equine health industry. Horse racing has become a royal sport in developed as well as developing countries. This is likely to boost the growth of the market during the forecast period. Moreover, orthopedic injuries in young horses have a significant economic impact, and hence is crucial to tackle the health concerns of horses and improve their health.
Request for Analysis of COVID-19 Impact on Equine Supplement Products Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66551
Increase in Awareness about Preventive Care among Equine Owners
Increase in awareness about preventive care among horse owners and trainers and rise in the use of micronutrient-based equine supplements to improve joint health are anticipated to boost the growth of the market during the forecast period. Moreover, horse owners are aware of high prevalence of equine lameness and metabolic disorders among horses, and hence use equine supplements to improve equine health and avoid alleviation of health conditions.
Strategic Approaches by Market Players to Boost Market Share
The report also provides profiles of leading players operating in the global equine supplement products market. These include Zoetis, Boehringer Ingelheim International GmbH, Bayer AG, Equine Products UK LTD, Purina Animal Nutrition LLC., Vetoquinol S.A., Kentucky Equine Research, Plusvital Limited, Lallemand, Inc., and Virbac. Partnerships, new product launches, and mergers & acquisitions are the key strategies adopted by market players to increase product sales and capture market share.
Buy Equine Supplement Products Market Report -
https://www.transparencymarketresearch.com/checkout.php?rep_id=66551<ype=S
For instance, in November 2017, Plusvital Limited launched EnerGene-Q10, nutrigenomic supplement to expand its equine supplements product portfolio and gain market share.
More Trending Reports by Transparency Market Research –
Sample Preparation Market: https://www.prnewswire.com/news-releases/technological-advancement-to-mark-sample-preparation-market-driving-growth-from-2019-to-2027-tmr-301145708.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Photobiostimulation Devices Market to Undertake Strapping Growth by the End 2027
Transparency Market Research (TMR) has published a new report on the photobiostimulation devices market for the forecast period of 2019 to 2027.
· According to the report, the global photobiostimulation devices market was valued at US$ 180 Mn in 2018, and is projected to expand at a CAGR of more than 6% from 2019 to 2027, to reach a market value exceeding US$ 300 Mn by 2027 end. The global photobiostimulation devices market is driven by the increased awareness and acceptance of photobiostimulation devices due to their proven benefits in applications such as pain management, wound care, cosmetic procedures, and other medical disorders.
· The global photobiostimulation devices market has been segmented based on wavelength type, application, end user, and region
· In terms of wavelength type, the global photobiostimulation devices market has been categorized into infrared light, red light, and others
· Based on application, the global photobiostimulation devices market has been classified into pain management, wound care, cosmetic applications, and others.
· In terms of end user, the global photobiostimulation devices market has been divided into specialty clinics, research institutions, home care, and others.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66995
Increase in Number of Patients with Chronic Pain and Other Chronic Illnesses to Drive Market
· The global photobiostimulation devices market is driven by the increasing incidences of chronic diseases, rapidly aging population, and rise in the availability of emergency medical services centers.
· Photobiostimulation has been investigated and clinically used for more than 30 years. Numerous studies have concluded that, photobiostimulation devices are effective for the treatment of musculoskeletal disorders, arthritis, wound care, and many more.
· Rapid increase in the incidence rate of chronic diseases across the globe will lead to a rise in the number of patients who will undergo treatment using techniques such as photobiostimulation and light therapy. This, in turn, is projected to increase the uptake of photobiostimulation devices, thereby boosting the growth of the photobiostimulation devices
· A number of international studies have estimated that, between 10.1% and 55.2% of the population is afflicted with pain. In the U.S., 20% to 30% of the general population experiences chronic or recurring pain. Approximately, two-thirds of these individuals have had pain for more than five years.
Request Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66995
Rise in Patient Preference for Minimally Invasive Therapies and Non-invasive Equipment
· The American Society of Plastic Surgeons estimated that, over 17.7 million minimally-invasive aesthetic procedures were performed in the U.S. in 2017, a 2% increase over 2016. This indicates the high popularity of minimally-invasive procedures in dermatological applications.
· For simple skin-related problems such as unwanted hair, wrinkles, and lines, patients prefer faster solutions with minimal pain that help them resume work at the earliest. Furthermore, the introduction of hand-held photobiostimulation devices is likely to increase convenience for service providers, thereby boosting the uptake of these devices, and, in turn, the growth of the photobiostimulation devices
Request for Analysis of COVID-19 Impact on Photobiostimulation Devices Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66995
Increase in Geriatric Population to Drive Demand for Photobiostimulation Devices for Pain Management, Wound Care, etc.
· Increase in the geriatric population is a major driver of the global photobiostimulation devices market. Elderly individuals increase the patient pool in major regions of the world. According to World Health Organization (WHO) estimates, the global geriatric population is likely to reach 2 billion (22% of the global population) by 2050, which was around 962 million in 2017.
· The global geriatric population is expected to increase at faster rate in developed countries such as the U.S., the U.K., and Japan. Brazil, China, Thailand, and South Korea are expected to have a large geriatric population in the shortest span of time in the near future.
· This increase in the geriatric population is anticipated to boost the growth of the photobiostimulation devices market, as this section of the population is more prone to various age-related as well as chronic diseases. The need for photobiostimulation devices among such patients is relatively higher, which increases the demand for photobiostimulation devices for pain management.
Cosmetic Applications Segment to Grow Rapidly in the Photobiostimulation Devices Market
· The photobiostimulation devices market report offers detailed segmentation of the global photobiostimulation devices market based on wavelength type, application, and end user. The cosmetic applications segment is expected to expand at a significant CAGR in the photobiostimulation devices market during the forecast period. The cosmetic or aesthetic industry has expanded at a double digit growth rate, as a majority of the population is inclined toward enhancing their aesthetic appearance, and has accepted minimally-invasive procedures as a way to look appealing.
· Additionally, rise in disposable income is anticipated to increase the number cosmetic procedures across the world, which, in turn, is expected to boost the demand for photobiostimulation devices during the forecast period.
· However, photobiostimulation devices are categorized as high-risk laser devices. Hence, the product undergoes rigorous clinical trials prior to a PMA (premarket approval). Such rigorous premarket approval tests make it expensive and difficult for organizations to get their product approved and out in the photobiostimulation devices market. This is likely to act as a restraint of the global photobiostimulation devices market during the forecast period.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=66995
North America Dominated the Global Photobiostimulation Devices Market
· North America was the leading market for photobiostimulation devices in 2018. Factors such as aging population, increase in incidences of pain and wound diseases, and highly structured healthcare industry are fueling the growth of the photobiostimulation devices market in the region.
· According to the National Center for Complementary and Integrative Health, in 2016, approximately 20% of adults in the U.S. had chronic pain, and 8% had high-impact chronic pain. This is likely to drive the demand for photobiostimulation devices for pain management during the forecast period.
Key Players Operating in the Global Photobiostimulation Devices Market
· The photobiostimulation devices market report also provides the profiles of leading players operating in the global photobiostimulation devices market. These include Thor Photomedicine Ltd., Bioflex Laser Therapy, Ingeneus Pty. Ltd., Biolight Technologies, TheraDome, Inc., BioCare Systems, Inc., Erchonia Corporation, and Theralase Technologies, Inc.
More Trending Reports by Transparency Market Research –
Medical Glove Market:
Durable Medical Equipment (DME) Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Non-invasive Ventilators Market to Witness Exponential Growth by 2027
The demand within the global non-invasive ventilators market is set to increase at a sound pace in the times to follow. There is little contention about the unprecedented use of ventilators across all major healthcare facilities. The development of high-performance ventilators has pushed the medical and healthcare industries towards fruition by reducing the mortality rate across several territories. In addition to this, majority of medical practitioners focus on developing a robust infrastructure that can aid the operations of the healthcare sector. The use of non-invasive ventilators has increased as healthcare units look to offer greater utility to ailing patients. In this scenario, the total volume of revenues within the global non-invasive ventilators market shall grow at a sturdy pace.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54720
In this review, Transparency Market Research (TMR) debunks several anomalies related to the growth of the global non-invasive ventilators market. The review is based on a comprehensive report added by TMR on the given market. It is estimated that the total worth of the global non-invasive ventilators market would touch US$ 2.7 Bn by the end of 2027. The CAGR of the global non-invasive ventilators market is tabulated at 6.0% over the period between 2019 and 2027.
Rising Incidence of Pulmonary Diseases
The use of non-invasive ventilators for patients suffering from pulmonary diseases has increased by leaps and bounds. Medical researchers attribute the rising incidence of lung diseases to growing pollution levels across the globe. There is a pressing demand for improved infrastructure, especially across high-end healthcare units. The central healthcare authorities of all leading countries are making deliberate efforts to increase the total number of ventilators available across that region.
Request for Analysis of COVID-19 Impact on Non-invasive Ventilators Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=54720
Moreover, the national development index of countries largely depends on the quality of healthcare equipment and devices available across various centers. This factor has compelled national healthcare bodies to increase their spending on buying life-sustaining equipment such as ventilators. Considering the factors stated above, it is legit to project that the global non-invasive ventilators market would grow by leaps and bounds over the next decade.
Outbreak of Covid-19 Pandemic
The healthcare industry is at an important juncture in the current times, majorly due to the outbreak of the covid-19 pandemic. Apart from causing widespread panic and concern across the healthcare industry, the pandemic has driven demand for several healthcare devices and equipment. Several nations have already taken a decision on increasing their healthcare spending.
Request Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=54720
A number of initiatives taken to consolidate non-healthcare sector has been pulled back, creating new opportunities for advancements in healthcare facilities. Therefore, the outbreak of this pandemic has led to the generation of fresh revenues for healthcare manufacturers. Supply chains of healthcare manufacturers have got special traction from state authorities. Easy availability and rebates on manufacturing shall create new opportunities for growth within the global non-invasive ventilators market.
Patients affected with coronavirus need to be put on ventilators in the most serious stages of treatment. Therefore, the growing incidence of the infection has compelled medical authorities to demand large stocks of ventilators from state bodies.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=54720
Several countries have released figures about the number of ventilators available at their disposable. This has helped in evaluating the unmet needs of the medical and healthcare industries of that particular region. Therefore, development of new centers and hubs for treatment of covid-19 shall play a vital role in the growth of the global non-invasive ventilators market. Several governments have funded special projects for manufacturing ventilators to contain rising mortality rates across the globe.
More Trending Reports by Transparency Market Research –
Digital Pathology Market:
Medical Lifting Slings Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Nasal Polyps Treatment Market to Record an Exponential CAGR by 2027
Transparency Market Research (TMR) has published a new report on the nasal polyps treatment market for the forecast period of 2019 - 2027. According to the report, the global nasal polyps treatment market was valued at ~ US$ 3.9 Bn in 2018, and is projected to expand at a CAGR of ~ 5% from 2019 to 2027.
Nasal Polyps Treatment Market: Overview
· The global nasal polyps treatment market is anticipated to be driven by the rise in the geriatric population suffering from chronic rhinosinusitis with nasal polyps (CRSwNP), rapid utilization of minimally-invasive surgeries by otorhinolaryngologist surgeons in developed regions, and rich pipeline of nasal polyps treatment options.
· North America held a major share of the global nasal polyps treatment market in 2018, due to the presence of a large population with nasal polyps, increase in incidences of CRSwNP, surge in the number of sinus surgeries, and rapid adoption of technologically-advanced products such as sinus implants in the U.S.
· The nasal polyps treatment market in Asia Pacific is expected to expand at a high CAGR of ~ 6% from 2019 to 2027, due to the surge in the target patient pool with inflammatory respiratory disorders, which is likely to drive the number of surgical procedures in emerging markets such as India and China.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53529
Rise in Prevalence of CRSwNP across the Globe to Drive Market
· Rise in the prevalence of inflammatory and respiratory diseases such as chronic rhinosinusitis, asthma, nasal polyps, and allergic rhinitis is expected to augment the global nasal polyps treatment market during the forecast period.
· Chronic rhinosinusitis (CRS) is a nasal inflammatory condition that affects the tissues deep inside the nasal passages and paranasal sinuses, causing symptoms that last for 8 weeks to 12 weeks or longer. The disease can occur with or without nasal polyposis.
· CRS is considered to be a serious nasal disorder, with a prevalence of 4.7% among the geriatric population aged 60 years and above. Moreover, it is the sixth most common chronic condition affecting the elderly population.
· Hence, rise in the prevalence and increase in the burden of chronic respiratory diseases such as chronic rhinosinusitis with nasal polyps will drive the need for treatments and therapies among patients. This could lead to an increase in the number of sinus surgical procedures, which, in turn, is likely to accelerate the growth of the global nasal polyps treatment market in the next few years.
Pharmacological Therapies in Demand
· In terms of treatment, the global nasal polyps treatment market can be classified into pharmacological therapies and surgeries. The pharmacological therapies segment can be divided into antibiotics, corticosteroids, leukotriene inhibitors, and others. The surgeries segment can be categorized into polypectomy and functional endoscopic sinus surgery (FESS).
· The pharmacological therapies segment dominated the global nasal polyps treatment market in 2018, and the trend is projected to continue during the forecast period. Pharmacological therapies including intranasal steroids, sprays, systemic & oral corticosteroids, nasal saline irrigations, and antibiotics are widely adopted for the treatment of patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
· Moreover, increase in the demand for topical and systemic corticosteroids with high potential to minimize the size of nasal polyps and prevent regrowth is anticipated to boost the growth of the segment in the nasal polyps treatment market.
Hospitals to be Promising End User
· Surgical options including polypectomy and functional endoscopic sinus surgery (FESS) for nasal polyps treatment are primarily performed in ambulatory surgical centers, hospitals, and specialty clinics. The hospitals segment is estimated to expand at a high CAGR during the forecast period, owing to an increase in the number of patients diagnosed with nasal polyps across the globe, leading to a rapid rise in sinus surgeries performed in operating rooms.
· Growth of the segment is attributed to increase in the availability of specialty care services in hospitals and the presence of qualified healthcare professionals in hospitals.
· The ambulatory surgical centers segment is expected to grow at a rapid pace in the next few years. Increase in the shift from operating rooms to ambulatory surgical centers for sinus surgeries due to greater efficiency, patient satisfaction, minimal length of stay, and lower infection rates is likely to boost the growth of the segment in the nasal polyps treatment market.
Request for Analysis of COVID-19 Impact on Nasal Polyps Treatment Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=53529
North America a Prominent Market; Asia Pacific to Offer Significant Incremental Opportunity
· In terms of region, the global nasal polyps treatment market has been segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America is projected to account for a leading share of the global nasal polyps treatment market during the forecast period, owing to an increase in the number of patients suffering from nasal polyps. For instance, nearly 200,000 new cases of nasal polyps are reported in the U.S. every year, which is anticipated to boost the nasal polyps treatment rate. This, in turn, is expected to drive the demand for medical therapy as well as escalate the number of sinus procedures performed in the country.
· Moreover, the favorable reimbursement scenario for nasal polyps treatment in the country is likely to drive the nasal polyps treatment market in North America.
· The nasal polyps treatment market in Asia Pacific is projected to grow at a rapid pace in the next few years. India, China, and South Korea are anticipated to be lucrative markets for nasal polyps treatment during the forecast period, owing to a rise in the patient population affected by chronic rhinosinusitis with nasal polyps.
· According to the National Center for Biotechnology Information (NCBI), approximately 8% of the population of China and 6.9% population of South Korea are affected by chronic rhinosinusitis. The disease can occur with nasal polyps and lead to nasal obstruction, facial pain, and inflammation in the sinuses, which is likely to drive demand for medications for treatment.
Growth Strategies of Key Players
· Key players operating in the global nasal polyps treatment market are Merck & Co, Inc., Intersect ENT, Inc., OptiNose US, Inc., Sanofi, Pfizer, GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., and Regeneron Pharmaceuticals, Inc.
· These companies engage in research and development activities as well as strategic collaborations and partnerships for new product launches in order to expand their product offerings and customer base.
· For instance, in April 2018, Intersect ENT, Inc. announced the launch of the SINUVA Sinus Implant in the U.S. SINUVA Sinus Implant is a mometasone furoate steroid eluting sinus implant used to treat recurrent nasal polyps in patients who have already undergone sinus surgery. The implant is used by physicians as an alternative to medication with limited efficacy for nasal polyps. This product launch enabled the company to expand its product portfolio and strengthen its position in the global nasal polyps treatment market.
More Trending Reports by Transparency Market Research –
Retinal Disorders Treatment Market:
Roadside Drug Testing Devices Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Mechanical Lithotripters Market to Register a Stout Growth by End 2026
A lithotripter is a device used for crushing stones present in the kidneys, bile, or pancreatic ducts. A mechanical lithotripter is a type of lithotripter most widely used for breaking bile stones. Mechanical lithotripters mainly consist of a metal sheath, wire basket, and handle to provide retraction of basket into the metal sheath. The baskets used in mechanical lithotripters are strong and large and enable the trapping of stones.
Read Report Overview -
https://www.transparencymarketresearch.com/mechanical-lithotripters-market.html
Mechanical lithotripters come in two types of designs: integrated devices and salvage devices. Integrated devices consist of all components such as metal sheath, wire basket, and handles, whereas salvage devices mainly consist of metal sheaths and handles. Integrated lithotripters are used for stones present anywhere within the duct. Salvage and integrated devices require more time to operate than standard stone extraction devices. Mechanical lithotripters are relatively less expensive compared with other lithotripsy devices.
Increase in the prevalence of kidney stones and bile stones are likely to drive the global mechanical lithotripters market. Additionally, an increase in the cases of thyroid disease, renal tubular acidosis, Crohn’s diseases are anticipated to drive the global mechanical lithotripters market. Moreover, an increase in the prevalence of urolithiasis is estimated to propel the global mechanical lithotripter market. According to the National Kidney Foundation, approximately 10% of the world’s population is affected by chronic kidney diseases.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59775
According to the Eastern Mediterranean Health Journal, the prevalence of upper urinary tract stones was high in children as well as adults. Adoption of minimally invasive procedures such as endoscopy and ureteroscopy is estimated to drive demand for mechanical lithotripters in the near future. Affordability of mechanical lithotripters and their lower adverse effects compared to shockwave lithotripsy devices are anticipated to augment the mechanical lithotripters market.
The global mechanical lithotripters market can be segmented based on type, application, and region. In terms of type, the mechanical lithotripters market can be divided into intraductal lithotripter, electrohydraulic lithotripter, and laser lithotripter. The growth of the electrohydraulic lithotripter segment can be attributed due to an increase in the prevalence of bile duct and pancreatic stones.
Get COVID-19 Analysis on Mechanical Lithotripters Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59775
Based on application, the mechanical lithotripters market can be divided into bile duct, gallbladder, and kidney stones. Rise in the prevalence of kidney stones due to renal tubular acidosis is anticipated to drive the kidney stone segment.
In terms of region, the global mechanical lithotripters market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market. The mechanical lithotripters market in the region is driven by various factors such as the presence of key players and rise in the incidence of kidney stone diseases. According to an article published in the Cleveland Clinic Journal of Medicine, 10% to 25 % of adults were suffering from gall bladder stones in 2015 in the U.S.. Approximately 13% of men and 7% of women in the U.S. are diagnosed with kidney stones once during their life.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59775
The mechanical lithotripters market in Europe is projected to expand at a rapid pace during the forecast period, due to an increase in the prevalence of kidney stones. In Germany, approximately 1% to 2% of people suffer from kidney stones each year. According to the British Association of Urological Surgeons, from January 2014 to December 2014, there were 2,042 procedures were estimated to be conducted in the U.K. The market in Asia Pacific is driven by an increase in the prevalence of bile duct stones and kidney stones. According to the Southern Cross, in New Zealand, 10% to 15% of the population was affected by kidney stones once in the lifetime.
The global mechanical lithotripters market is highly fragmented, due to the presence of a large number of players. Key players operating in the global mechanical lithotripters market are ENDO-FLEX GmbH, Cook, Boston Scientific Corporation, Olympus America, Medi-Globe GmbH, Endo-Med Technologies Pvt. Ltd., and others.
More Trending Reports by Transparency Market Research –
mHealth Services Market:
Sinusitis Treatment Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Atherosclerosis Therapeutics Market to Surge at a Robust Pace by 2031
Atherosclerosis Therapeutics Market: Introduction
Atherosclerosis is the thickening, hardening, and loss of elasticity of the walls of the arteries. It is also known as arteriosclerosis. Atherosclerosis results in plaque formation inside the arteries. Arteries are blood vessels that carry blood from the heart to other parts of the body. Arteries are lined by a thin layer of cells known as endothelium.
Read Report Overview -
https://www.transparencymarketresearch.com/atherosclerosis-therapeutics-market.html
Atherosclerosis begins with the damage of endothelium due to smoking, high cholesterol, and high blood pressure. That damage leads to the formation of plaque. Plaque is made of calcium, cholesterol, fat, and other substances found in the blood.
Accumulation of plaque causes hardening and narrowing of the arteries. Gradually, plaque grows in size and may partially or totally block blood flow and reduce blood flow to organs such as the heart and other parts of your body. This can lead to serious problems including stroke, heart attack, or even death. Atherosclerosis can affect any artery in the body, including arteries in the legs, brain, heart, arms, pelvis, and legs, resulting in the development of different diseases based on which arteries are affected. Atherosclerosis plaques causes three main types of cardiovascular diseases: coronary artery disease, cerebrovascular disease, and peripheral artery disease.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59790
Coronary heart disease (CHD) or coronary artery disease is a major cause of death and disability across the world. CHD is responsible for about one-third or more of total deaths in the population over age 35. It is estimated that one-third of middle-aged women and half of all middle-aged men in the U.S. develop some manifestation of coronary heart disease.
Key Drivers, Restraints, and Opportunities of Global Atherosclerosis Therapeutics Market
The global atherosclerosis therapeutics market is expected to expand, due to an increase in the geriatric population and rise in the incidence rate of heart attacks due to coronary heart disease or atherosclerosis. Additionally, availability of new treatment approaches (branded and generic) is a key factor driving the global atherosclerosis therapeutics market. According to the Centers for Disease Control and Prevention (CDC), about 610, 000 people from the U.S. died due to heart diseases, which is nearly one in every four deaths. Among heart diseases, coronary artery disease is a highly common heart disease, causing about 370,000 deaths per year. These factors are estimated to boost the global atherosclerosis therapeutics market. However, dependence on symptom-based treatment in several cases and limited efficacy and side-effects of the drugs available in the market are expected to restrain the global atherosclerosis therapeutics market during the forecast period.
Get COVID-19 Analysis on Atherosclerosis Therapeutics Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59790
North America to Capture Major Share of Global Atherosclerosis Therapeutics Market
In terms of region, the global atherosclerosis therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market during the forecast period due to the presence of major players, higher cases of cardiovascular diseases and atherosclerosis, and well-established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are key factors that are anticipated to boost the market.
The U.S. held a major share of the market in North America due to supportive healthcare policies, a high number of patients, and a developed healthcare market. About 647,000 people in the U.S. die from heart disease every year, i.e., 1 in every 4 deaths. Heart disease costs the U.S. around US$ 219 billion each year. According to statistics, an increase in patient pool and disposable income in this country propels the market of the region.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59790
Key Players Operating in Global Atherosclerosis Therapeutics Market
The atherosclerosis drugs market is moderately competitive and includes major players. Major players operating in the global atherosclerosis therapeutics market are:
· Pfizer Inc.
· AstraZeneca
· Merck & Co., Inc.
· Sanofi US
· Amgen Inc.
· Novartis AG
· GlaxoSmithKline Plc
· Bayer AG
· Mylan N.V.
· Eli Lilly and Company
· F. Hoffmann-La Roche Ltd.
· Isis Pharmaceuticals, Inc.
· Anthera Pharmaceuticals
· Johnson and Johnson
· Cardium Therapeutics
· The Medicine Company
More Trending Reports by Transparency Market Research –
Vascular Closure Devices Market:
Private Healthcare Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
Marijuana Drying and Curing Equipment Market Expected to Witness a Sustainable Growth by 2026
Global Marijuana Drying and Curing Equipment Market: Overview
The global marijuana drying and curing equipment market has grown steadily over the years, owing to the pivotal role of marijuana in relieving pain. Marijuana drying and curing equipment helps in determining the actual timings for harvesting and drying marijuana plants. This equipment also helps in avoiding contamination, oil preservations, and moisture variations. The incorporation of advanced technology in marijuana drying and curing equipment ensures smooth burning and flavorful taste of properly grown, cured and dried marijuana flowers.
An upcoming report on the global marijuana drying and curing equipment market by Transparency Market Research could be a valuable source of information for major stakeholders in the market. This is because of the exhaustive information, gathered after thorough primary and secondary research, contained in it.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59628
The report would be an objective guideline of growth drivers, restraints, opportunities, and pitfalls in the market. The report would also offer a brilliant study of the market as it focus on market dynamics, segmentation, competitive landscape, and geographical outreach. It is a useful guidelines for players to cement a strong position in the global marijuana drying and curing equipment market.
Global Marijuana Drying and Curing Equipment Market: Key Trends
Growing number of countries legalizing cannabis for recreational and medical consumption, and increasing cultivation rate of cannabis are believed to be driving the global marijuana drying and curing equipment market. Marijuana helps in relieving pain for the patients suffering from chronic diseases such as migraine, arthritis, epilepsy, and cancer. Thus, the opting rate of cannabis is rising, which is anticipated to boost the global marijuana drying and curing equipment market. Along with these, growing demand for high quality marijuana, which are produced through organic methods, and rising usage of marijuana for treating various medical conditions are also expected to fuel the global marijuana drying and curing equipment market.
Get COVID-19 Analysis on Marijuana Drying and Curing Equipment Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59628
Furthermore, rising preference of marijuana drying and curing equipment over conventional methods for maintaining optimum external conditions, and preserving active ingredients, and growing demand for higher product quality and quantity are projected to propel the global marijuana drying and curing equipment market. Apart from these, rising legalization of hemp across the globe, and increasing investments in developing cultivation facilities and technologically advanced equipment for drying and curing cannabis are also believed to thrust the global marijuana drying and curing equipment market.
Global Marijuana Drying and Curing Equipment Market: Regional Outlook
Geographically, North America is expected to lead the global marijuana drying and curing equipment market as the region has seen rapid technological advancements. Rising quality standards for cultivation, growing consumer demand for potent marijuana, and increasing cases of painful diseases could also be responsible for fueling the marijuana drying and curing equipment market in this region.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59628
Other prominent countries in the global marijuana drying and curing equipment market are Germany, and Australia. Increasing approaches toward indigenous production is anticipated to boost the marijuana drying and curing equipment market in these countries.
Global Marijuana Drying and Curing Equipment Market: Competitive Dynamics
Key players operating in the global marijuana drying and curing equipment market include Darwin Chambers, Autocure, Cann systems, Yofumo Technologies, Conviron, and En Wave corporation.
More Trending Reports by Transparency Market Research –
Dura Substitute Market:
Companion Diagnostics Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Specimen Retrieval Systems Market Estimated to Expand at a Robust CAGR by 2026
The life sciences sector comprises pharmaceutical, biotech, and health care segments. It is progressively achieving profitable revenues globally. This has been partly attributed to emerging markets and positive demographics in those markets as well as due to global leading edge research resulting in blockbuster innovations. These innovations are facilitated by meticulous and vigorous R&D efforts by global players and academia in all the aforementioned segments. R&D requires high throughput sampling and analysis. Hence, it is driving the specimen retrieval system market.
A specimen retrieval system can be defined as an easy-to-use retrieval system that is specifically designed to temporarily retain specimen and further facilitate its removal from the patient during the course of laparoscopic surgery. It is designed to minimize the contamination of the abdominal cavity. It also helps improve patient outcomes and provide better patient safety.
The specimen retrieval systems market is projected to grow at a significant pace during the forecast period. A major factor promoting the growth of this market is a rise in the prevalence of diseases that require surgical treatment, specifically laparoscopic surgeries. However, the high cost of specimen retrieval systems may act as hurdle for the growth of this market, especially in emerging countries.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60492
The global specimen retrieval systems market can be segmented based on product, application, and region. Based on product, the global specimen retrieval systems market can be classified into detachable and non-detachable specimen retrieval systems. In terms of application, the global specimen retrieval systems market can be categorized into gastrointestinal surgery, gynecological surgery, urological surgery, and others (cardiovascular and bariatric). Based on end-user, the specimen retrieval systems market can be divided into hospitals & clinics, ambulatory surgical centers, and others.
Based on product, the non-detachable specimen retrieval systems segment is expected to account for a prominent market share in 2018. The segment is anticipated to expand at a high CAGR during the forecast period, owing to a rise in the number of MIS procedures, especially in emerging markets. In terms of application, the gastrointestinal surgery segment is expected to expand at a high CAGR over the forecast period. Factors such as rise in the prevalence of gastrointestinal diseases such as appendicitis and gallstones and technological advancements in gastrointestinal robotic surgery are expected to boost demand for specimen retrieval systems.
Get COVID-19 Analysis on Specimen Retrieval Systems Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60492
In terms of region, the global specimen retrieval systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to constitute a major market share in 2018. However, the market in Asia Pacific is expected to expand at a rapid CAGR in the coming years. Increase of income levels in emerging markets such as India and China is leading to a rise in health care spending.
Moreover, changing lifestyles and increasing urbanization in these countries have led to a gradual escalation in the incidence of life style related diseases such as cancer, diabetes, and heart disease. This has opened up multiple avenues for expansion in the bio-pharmaceutical sector to conduct research and allocate substantial budget for the same. Increasing awareness and level of education among consumers and end-users is driving the life sciences industry to consistently provide value and superior market level positioning regarding their product’s efficacy. These factors are likely to drive the specimen retrieval systems market during the forecast period.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60492
Major players operating in the global specimen retrieval systems market include Applied Medical Resources Corporation, Johnson & Johnson Services, Inc., Cooper Surgical, Inc., B. Braun Melsungen AG, Teleflex Incorporated, Medtronic, Conmed Corporation, Genicon, Laprosurge, and Purple Surgical. Johnson & Johnson (Ethicon) is a prominent player in the specimen retrieval systems market. It has a strong foothold in this market, owing to a strong global distribution network and significant brand reputation among end-users.
More Trending Reports by Transparency Market Research –
Sinus Dilation Devices Market:
Monopolar Electrosurgery Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
Ophthalmic Surgical Devices and Therapeutics (Eye Care) Market to Develop Rapidly by 2026
Transparency Market Research (TMR) has published a new report titled, “Ophthalmic Surgical Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the ophthalmic surgical devices and therapeutics market is expected to reach at US$ 43,794.4 Mn by the end of 2018. The market is anticipated to reach US$ 68,898.4 Mn by 2026 and expand at a CAGR of 5.8% from 2018 to 2026. Rise in number of geriatric patients, increase in awareness regarding eye disorders, and high unmet medical needs are expected to augment the global market from 2018 to 2026. The ophthalmic surgical devices and therapeutics market is projected to expand owing to an increase in the prevalence of eye-related disorders among the population, demand for better treatments, and developing healthcare infrastructure in various countries across the globe.
Increasing geriatric population and rising awareness regarding eye diseases
According to data published by the United Nations Department of Economics and Social Affairs, the geriatric population is expected to double by the end of 2050 and is projected to reach nearly 2.1 billion. This increasing geriatric population is prone to significant risk of eye-related disorders, including blindness. Public awareness regarding common eye conditions is increasing in developing countries, leading to early diagnosis and treatment of eye diseases. Furthermore, there are a large number of organizations dedicated to fight blindness, restore vision, and create awareness regarding eye health. National Eye Institute, National Association for Visually Handicapped, National Federation of the Blind, and Prevent Blindness are some eye health organizations concerned with prevention of eye diseases.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60669
Increase in incidence rates of eye related disorders
According to the World Health Organization (WHO), there are 285 million visually impaired people globally, approximately 90% of them reside in low to middle income countries. Furthermore, approximately 95 million people suffer from cataract, and 20 million suffer from various eye conditions, including glaucoma, muscular degeneration, infections, and childhood-related conditions. Significant rise in incidence of eye-related diseases, especially in developed countries, is anticipated to drive the ophthalmic surgical devices and therapeutics market between 2018 and 2026.
Patients undergoing open angle glaucoma and age related macular degeneration (AMD) in the U.S., were 2.7 million and 2.1 million, respectively. This number is projected to increase to 3.3 million and 2.5 million, respectively, by 2020. Increasing patient pool in developing countries as well as developed countries is estimated to propel healthcare spending for eye treatments in these countries and drive the ophthalmic surgical devices and therapeutics market.
High unmet needs for refractive corrections
According to an article published by the British Journal of Visual Impairment, refractive errors are the leading cause of visual impairment and at the same time, most treatable cause of visual impairment in children. Furthermore, according to this article, more than 90% of people with refractive errors reside in low-income and poor countries and cost is a major obstacle to accessing glasses and meeting the need for correction. Studies indicate that rates of willingness to pay for glasses are low, and cost and affordability is a primary reason for not using glasses in China, India, countries in Africa, and several developing countries across the globe.
Get COVID-19 Analysis on Ophthalmic Surgical Devices and Therapeutics Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60669
Therapeutics segment dominates the global market due to its choice as first line of treatment for ocular diseases
In terms of product type, therapeutics is a highly attractive segment of the global ophthalmic surgical devices and therapeutics market, followed by surgical devices and vision care segments. This is attributable to the preference for drugs as the first line of treatment for any eye-related diseases. Expansion of the segment is primarily attributed to the increased prevalence of glaucoma and ocular infections among the population. According an article published by the American Academy of Ophthalmology, the global prevalence of glaucoma for population aged 40 to 80 years is 3.54%. The prevalence of primary open-angle glaucoma is considerably high in Africa, i.e., 4.2%, and the prevalence of primary angle-closure glaucoma (PACG) is significantly high in Asia, i.e., 1.09%.
North America dominates the global market owing to significant technological advancements in the region
North America dominates the global ophthalmic surgical devices and therapeutics market due to a large patient pool, high cost of specialty branded drugs, high cost of ocular surgeries, and increase in the geriatric population in the region. The region is estimated to maintain its dominance during the forecast period. According a U.S eye disease statistics, published by the American Academy of Ophthalmology, cataract, age-related macular degeneration, glaucoma, and diabetic retinopathy are the most common causes of visual impairment among the population in the U.S.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60669
Additionally, approximately 7.32 million people in the U.S. are expected to suffer from primary open-angle glaucoma by 2050. Moreover, rising healthcare expenditure and increasing investments are key factors that are anticipated to boost the ophthalmic surgical devices and therapeutics market in the next few years. The ophthalmic surgical devices and therapeutics market in Asia Pacific is projected to expand at a notable CAGR due to increasing awareness regarding eye diseases in developing countries and government initiatives introduced in the region.
Investments by key players is driving the global ophthalmic surgical devices and therapeutics market.
Key players dominating the ophthalmic surgical devices and therapeutics market include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG.
More Trending Reports by Transparency Market Research –
Diagnostic Imaging Services Market:
Synthetic Biology Market:
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
 Market to Develop Rapidly by 2026)
Mumps Market to Observe Strong Development by 2031
Mumps Market: Introduction
Mumps is a contagious disease caused due to the mumps virus, which typically affects children. The symptoms of the disease include headache, muscle aches, loss of appetite, tiredness, and fever. Additionally, swelling on one or more salivary glands is also observed. Additionally, these diseases are transmitted from person to person due to contact of saliva or droplets.
Read Report Overview -
https://www.transparencymarketresearch.com/mumps-market.html
Complications involves deafness and a wide range of inflammatory conditions of which inflammation of the breasts, testes, ovaries, pancreas, meninges, and brain are highly common. Testicular inflammation usually results in reduced fertility and, rarely, sterility. Humans are the natural host of the mumps virus, an RNA virus in the family Paramyxoviridae. The virus is basically transmitted by respiratory secretions including droplets and saliva as well as via direct contact with an infected person. Mumps is highly contagious and spreads easily in densely populated settings.
Transmission could occur from one week before the onset of symptoms to eight days after. During infection, the virus primarily infects the upper respiratory tract. Subsequently, mumps spreads to the salivary glands and lymph nodes. Infection of the lymph nodes leads to presence of the virus in blood, which transmits the virus throughout the body. Mumps infection is basically self-limiting, coming to an end as the immune system clears the infection.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59613
Mumps could be diagnosed based on clinical presentation in regions where it is common. In places where mumps is rare, however, laboratory diagnosis utilizing viral cultures, antibody testing, or real-time reverse transcription polymerase chain reaction must be needed. There is no specific treatment for mumps, therefore treatment is assistive in nature and consists of bed rest and pain relief. Prognosis is basically excellent with a full recovery, as death and long-term complications are rare. Infection could be prevented with vaccination, either via an individual mumps vaccine or through combination vaccines including the MMR vaccine that also protects against measles and rubella. The spread of the disease could even be prevented by isolating infected individuals.
Key Drivers, Restraints, and Opportunities of Global Mumps Market
The mumps market is estimated to expand due to growing acceptance of vaccination globally, especially from developed countries such as India and China. High birth rate across these countries coupled with rising awareness about the acceptance of these vaccinations is propelling the mumps market. Additionally, high demand for the mumps vaccine from developed countries is further boosting its demand and fueling the global mumps market.
Get COVID-19 Analysis on Mumps Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59613
Vaccine manufacturers are emphasizing on collaboration with organizations including UNICEF, WHO, and GAVI Alliance to enhance their vaccination programs in order to reach the maximum population to provide vaccines. Mumps is leading cause of death among young children in spite of various governmental initiatives. Thus, a rise in success rate of vaccination schemes depends on government initiatives of each country. Increase in air pollution levels due to rising industrialization is driving airborne diseases worldwide such as mumps, which is a significant airborne disease. Initial symptoms related to this disease include cough, fever, redness in the eyes and running nose along with rashes on the body.
However, the number of patients from Asia Pacific and North America is decreasing. Earlier, diseases was expanding rapidly, which was propelling the mumps market. However, a rise in the demand for arresting the disease is fueling the mumps market.
North America to Capture Major Share of Global Mumps Market
In terms of region, the global mumps market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate the mumps market due to the high rate of vaccination and high expenses on vaccinations and treatments in the region. The market in Asia Pacific is anticipated to account for the leading share and is expected to expand with high CAGR over the forecast period.
Asia Pacific is anticipated to expand at a high CAGR driven by government initiatives and free immunization programmes against mumps in the region. The market in Latin America and Middle East & Africa is anticipated to expand significantly driven by low cost of vaccinations in these regions. The cost of mumps vaccinations is less than US$ 1 in these regions.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59613
Key Players Operating in Global Mumps Market
The global mumps market is highly fragmented, with the presence of various key players. Major players are actively emphasizing on various growth strategies in order to gain a competitive advantage in the industry. Collaborations, partnerships, agreements, and new product launches are some of the important strategies that are adopted by market players. Increasing competition among major players to develop new therapy and technology for mumps would drive the market globally. Major players operating in the global mumps market are:
· MedImmune
· Johnson & Johnson Private Limited
· Merck & Co., Inc.
· Sanofi
· Serum Institute of India Pvt. Ltd.
· Bavarian Nordic
· Astellas Pharma India Private Limited
· CSL Limited
· Emergent BioSolutions Inc.
· GlaxoSmithKline plc
· Emergent BioSolutions, Inc.
· Pfizer
· Novartis International AG
· Bavarian Nordic A/S
· JC Medical
· China National Biotec Group Comp. Ltd.
More Trending Reports by Transparency Market Research –
Medical Devices Outsourcing Market:
Exosome Technologies Market:
https://www.prnewswire.com/news-releases/exosome-technologies-market-to-cross-us-300-mn-by-2031-finds-tmr-study-301491730.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Handicap Assistive Robots Market to Witness Comprehensive Growth by 2026
Handicap assistive robots, also known as disability robots, are designed to help people who have physical disabilities that impede their daily tasks. These are also employed for people recovering from diseases such as stroke or abstained injuries. Children with severe physical disabilities become dependent on others and lose interests in their surroundings and studies.
Read Report Overview -
https://www.transparencymarketresearch.com/handicap-assistive-robots-market.html
Robotic arms are becoming increasingly popular among them as they help them with their daily activities. The United Nations defines disability as a discrepancy that arises between personal abilities on one hand and demands of the environment and society on the other.
Handicap assistive robots can sense, process sensory information, and perform actions that assist elderly people and people with disabilities. Rise in number of people suffering from physical disabilities is boosting the demand for assistive technologies. Assistive robots can be considered the future of disability aids, ensuring proper care of the elderly and disabled population. The global handicap assistive robots market is expected to grow rapidly during the forecast period owing to rise in adoption of advanced technologies such as robotics.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60459
Rise in adoption of microprocessor controlled prosthetics (MPC prosthetics), handicap assistive robots, and health care exoskeleton systems; increase in the number of accidents leading to disabilities; growing health care spending; and economic growth of countries with large number of people with disabilities such as India and China are likely to drive the global handicap assistive robots market during the forecast period. However, lack of awareness about available technologies and high cost of robotic devices are anticipated to restrain the growth of the market in developing regions of the world.
The global handicap assistive robots market can be segmented based on product type, body function, robot’s mobility, end-user, and region. Based on product type, the market can be categorized into robotic wheelchairs, assistive robotic devices, and mobility-aid exoskeletons. Among these, robotic wheelchairs are likely to hold major share of the global handicap assistive robots market during the analysis period.
Get COVID-19 Analysis on Handicap Assistive Robots Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60459
In terms of body function, the global handicap assistive robots market can be classified into upper-extremity robots and lower-extremity robots. Based on robots mobility, the global handicap assistive robots market can be divided into mobile robots and fixed robots. In terms of end-user, the market can be bifurcated into hospitals, disability care centers, old age homes, home care settings, others.
Based on region, the global handicap assistive robots market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to be the leading market for handicap assistive robots owing to the presence of large population suffering from physical disabilities, high disposable income, growing research and development activities, and launch of advanced robotic systems in the region.
Enquiry Before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60459
Moreover, government initiatives regarding care of handicap people and availability of favorable reimbursement policies are likely to propel the growth of the global handicap assistive robots market in North America during the forecast period. Europe is likely to be the second largest market for handicap assistive robots due to strong government funding and high awareness about advanced technologies for handicap persons in the region.
Key players operating in the global handicap assistive robots market include Assistive Innovations BV, Bioness Inc., Ekso Bionics, Focal Meditech BV, Qode Interactive, Invacare Corporation, Kinova Inc., ReWalk Robotics, and Topchair SAS.
More Trending Reports by Transparency Market Research –
Smart Medical Devices Market:
Remote Patient Monitoring Devices Market:
https://www.globenewswire.com/news-release/2022/02/28/2393395/0/en/Remote-Patient-Monitoring-Devices-Market-to-Cross-Valuation-of-US-3-4-Bn-by-2030-Says-TMR.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Cellulitis Treatment Market Trends and Forecast to 2026
Cellulitis is one of the common skin infections caused by bacteria; mostly streptococcus sp. and staphylococcus sp. According to a study published by the AMA Journal of Ethics, cellulitis is defined as an acute inflammatory disorder which takes place in dermis and subcutaneous layer of the tissue. It can occur in any part of the body; however, lower legs and surrounding areas of wrist and fingers (face and neck in children) are mostly infected by streptococcus sp. and staphylococcus sp. Common symptoms of cellulitis include swelling, skin redness, fever, red spots, and skin dimpling.
Global Antimicrobial Susceptibility Test Market to Expand with a CAGR of 4.6% due to Growing Awareness about Bacterial Diseases | BioSpace
Transparency Market Research (TMR) witnesses the global antimicrobial susceptibility test market has a highly competitive vendor landscape. Some of the companies dominating the global antimicrobial susceptibility test market are Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Dickinson and Company, and Creative Diagnostics. These players are trying to expand product offerings and business expansion for widening customer base.
